Developing Therapeutics for Alzheimer's Disease

Developing Therapeutics for Alzheimer's Disease
Author :
Publisher : Academic Press
Total Pages : 676
Release :
ISBN-10 : 9780128021644
ISBN-13 : 0128021640
Rating : 4/5 (640 Downloads)

Book Synopsis Developing Therapeutics for Alzheimer's Disease by : Michael S. Wolfe

Download or read book Developing Therapeutics for Alzheimer's Disease written by Michael S. Wolfe and published by Academic Press. This book was released on 2016-05-27 with total page 676 pages. Available in PDF, EPUB and Kindle. Book excerpt: Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer’s disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area. Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer’s disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer’s disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics. Provides a realistic but promising assessment of the potential of various therapeutic approaches to Alzheimer’s disease Focuses primarily on neuroprotective agents and cognitive enhancers, as well as approaches to targeting the amyloid B-peptide, tau and Apolipoprotein E Discusses alternative approaches, preclinical and clinical development issues, related biomarkers and diagnostics, and prevention and nonpharmacological approaches


Developing Therapeutics for Alzheimer's Disease Related Books

Developing Therapeutics for Alzheimer's Disease
Language: en
Pages: 676
Authors: Michael S. Wolfe
Categories: Medical
Type: BOOK - Published: 2016-05-27 - Publisher: Academic Press

DOWNLOAD EBOOK

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeut
Alzheimer's Disease
Language: en
Pages: 254
Authors: Ahmed Moustafa
Categories: Medical
Type: BOOK - Published: 2021-08-28 - Publisher: Academic Press

DOWNLOAD EBOOK

Nearly 44 million people have Alzheimer’s or related dementia worldwide, according to the Alzheimer’s Disease International organization. That number is exp
Alzheimer's Disease Drug Development
Language: en
Pages: 575
Authors: Jeffrey Cummings
Categories: Business & Economics
Type: BOOK - Published: 2022-03-31 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in th
Alzheimer's Disease Drug Development
Language: en
Pages: 575
Authors: Jeffrey Cummings
Categories: Medical
Type: BOOK - Published: 2022-03-31 - Publisher: Cambridge University Press

DOWNLOAD EBOOK

Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizati
Alzheimer’s Disease Theranostics
Language: en
Pages: 80
Authors: Magisetty Obulesu
Categories: Medical
Type: BOOK - Published: 2019-01-20 - Publisher: Academic Press

DOWNLOAD EBOOK

Alzheimer’s Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer’s patients